Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 9Sarcoma 3Breast 3CNS 2Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Sarcoma 1Osteosarcoma 1Liposarcoma 1Leiomyosarcoma 1

Interventions

Specimen Handling 14Magnetic Resonance Spectroscopy 14Doxorubicin 12Cyclophosphamide 11Temozolomide 9Biopsy 9Radiation 8atezolizumab 7Radiotherapy 7X-Rays 6Vincristine 6Nivolumab 6Etoposide 6Bevacizumab 6pembrolizumab 5liposomal doxorubicin 5fludarabine 5cabozantinib 5Sirolimus 5Phantoms, Imaging 5Irinotecan 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Nuclear Medicine Department, Hospital 4temsirolimus 3palbociclib 3olaparib 3fludarabine phosphate 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Sarcoma × 30 days × Clear all
NCT05691478 2026-06-03

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
274 enrolled
Sarcoma

Sarcoma

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡